Effectiveness of a Community-delivered Integrated Malaria Elimination (CIME) Model in Myanmar
Evaluation of the Effectiveness and Cost-effectiveness of a Community-delivered Integrated Malaria Elimination (CIME) Model in Myanmar: An Open Stepped-wedge Cluster-randomised Controlled Trial
1 other identifier
interventional
6,440
0 countries
N/A
Brief Summary
In Myanmar, community health workers, known as malaria volunteers, have played a key role in reducing the malaria burden in the malaria control phase, providing essential malaria services in rural areas where the coverage of formal health services is limited. However, the community-delivered models that have worked well for malaria control may not work well for malaria elimination. In parallel with switching from interventions for malaria control to those for elimination, the motivation and social importance of malaria volunteers has declined along with the decline of the malaria burden. To sustain volunteer motivation, the social importance and effectiveness in the malaria elimination program, the Community-delivered Integrated Malaria Elimination model for Myanmar (CIME model) was developed based on global evidence and qualitative consultations with community members, leaders, volunteers and health stakeholders in Myanmar. This study will assess the level of effectiveness of the CIME model in increasing malaria testing by its application in an open cluster-randomised controlled stepped-wedge trial.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2021
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 19, 2020
CompletedStudy Start
First participant enrolled
January 1, 2021
CompletedFirst Posted
Study publicly available on registry
January 5, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2021
CompletedJanuary 5, 2021
January 1, 2021
6 months
December 19, 2020
January 3, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Blood examination rate
Change in blood examination rate as determined by the number of rapid diagnostic tests (RDTs) for malaria performed per week per village
Assessed weekly, longitudinally over 6-months
Secondary Outcomes (18)
Plasmodium spp. infection detected by RDT
Assessed weekly, longitudinally over 6-months.
Plasmodium spp. infections reported with 24 hours
Assessed weekly, longitudinally over 6-months.
Plasmodium spp. infection detected by PCR
Assessed weekly, longitudinally over 6-months.
Larval source management
Assessed weekly, longitudinally over 6-months.
Dengue cases
Assessed weekly, longitudinally over 6-months.
- +13 more secondary outcomes
Study Arms (2)
CIME intervention
EXPERIMENTALCommunity-delivered Integrated Malaria Elimination (CIME). The CIME intervention model integrates interventions for malaria, dengue, tuberculosis, childhood diarrhoea and RDT-negative fever.
ICMV standard of care
NO INTERVENTIONIntegrated Community Malaria Volunteer (ICMV) model - this is the current standard of care. This model involves malaria volunteers undertaking additional screening and referral services for a range of other diseases including: dengue, lymphatic filariasis, tuberculosis, HIV/AIDS and leprosy.
Interventions
Malaria: Malaria Diagnosis using RDT, treatment, referral and reporting; Prevention interventions (Behavioral Change Communication, net and repellent distribution); assisting in case and foci investigation and larval source management. Dengue: Assisting in dengue prevention; Referral of cases. Tuberculosis (TB): Detection and referral of suspected cases; Contact tracing; Directly observed treatment, short-course (DOTS) providers; defaulter tracing; follow-up sputum examinations; assisting in TB health education talks and active case detection activities. Childhood diarrhea: Prevention; Health education and Water, sanitation and hygiene (WASH) promotion; Diagnosis and dehydration assessment; Treatment and referral; Rehydration therapy using Oral Rehydration Solution (ORS) and oral Zinc tablet; assisted referral. RDT-negative fever: Prevention and health education; Symptomatic treatment with antipyretics and immediate assisted referral.
Eligibility Criteria
You may qualify if:
- Villages in Ayeyarwaddy, Bago and Yangon Regions and Kayah State townships in Myanmar with National Malaria Control Program (NMCP) trained Integrated Community Malaria Volunteers (ICMVs).
You may not qualify if:
- Townships
- A township will be excluded from the study if:
- The township does not have an NMCP provided ICMV network
- The township has ongoing armed conflict
- The township does not have Vector-Borne Diseases Control (VBDC) staff or malaria focal person
- The location of the township is not geographically or politically feasible for staff from the State/Regional capital city to conduct regular supervision visits
- Villages
- The village is too remote and unable to execute the CIME model completely,
- The village has a government public health facility,
- The village has no mobile network coverage
- The village is in the ongoing armed conflict zone , or
- The village has an ICMV program operated by any organizations other than NMCP
- The village has an Annual Parasite Index (API) \>=5
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (2)
Win Han Oo, Htike W, May Chan Oo, Pwint Phyu Phyu, Kyawt Mon Win, Nay Yi Yi Linn, Tun Min, Ei Phyu Htwe, Aung Khine Zaw, Kaung Myat Thu, Galau NH, Cutts JC, Simpson JA, Scott N, O'Flaherty K, Agius PA, Fowkes FJI. Effectiveness of an expanded role for community health workers on malaria blood examination rates in malaria elimination settings in Myanmar: an open stepped-wedge, cluster-randomised controlled trial. Lancet Reg Health Southeast Asia. 2024 Oct 17;31:100499. doi: 10.1016/j.lansea.2024.100499. eCollection 2024 Dec.
PMID: 39492851DERIVEDOo WH, Thi A, Htike W, Agius PA, Cutts JC, Win KM, Yi Linn NY, Than WP, Hkawng GN, Thu KM, Oo MC, O'Flaherty K, Kearney E, Scott N, Phyu PP, Htet AT, Myint O, Lwin Yee L, Thant ZP, Mon A, Htike S, Hnin TP, Fowkes FJI. Evaluation of the effectiveness and cost effectiveness of a Community-delivered Integrated Malaria Elimination (CIME) model in Myanmar: protocol for an open stepped-wedge cluster-randomised controlled trial. BMJ Open. 2021 Aug 13;11(8):e050400. doi: 10.1136/bmjopen-2021-050400.
PMID: 34389579DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Freya Fowkes, DPhil
Burnet Institute
- PRINCIPAL INVESTIGATOR
Win Han Oo, PhD
Burnet Institute
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 19, 2020
First Posted
January 5, 2021
Study Start
January 1, 2021
Primary Completion
July 1, 2021
Study Completion
July 1, 2021
Last Updated
January 5, 2021
Record last verified: 2021-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
- Time Frame
- Supporting information will be published in peer-reviewed journals within 2 years of study completion.
- Access Criteria
- Supporting information can be requested from study investigators
De-identified individual participant data will be available after publication from the data custodian(s) to applicants who provide a sound proposal to The Ethics Review Committee on Medical Research Involving Human Subjects, Department of Medical Research, Myanmar Ministry of Health and Sports (No. 5 Ziwaka Road, Dagon PO Yangon, Myanmar; (+95) 01 375447 extension 118; ercdmr2015@gmail.com) contingent of their approval.